| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
MRC Cyclotron Unit, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK
Several reports have described decreased oxygen extraction fractions in tumours relative to those in normal tissues as measured with the oxygen-15 steady state technique and positron emission tomography. The present simulation study was carried out to assess the influence of tissue heterogeneity on these measured values. It was found that, within the range analyzed, tissue heterogeneity always resulted in underestimations of mean values of oxygen extraction fraction. It must, therefore, be concluded that the oxygen-15 steady state technique is not an accurate method for the assessment of the oxygen status of tumours. This finding should also apply to other pathological conditions, where a significant degree of tissue heterogeneity can not be excluded. More generally, this study demonstrates the need for detailed analyses of sensitivities of tracer kinetic procedures to tissue heterogeneity.
Key Words: Oxygen extraction fraction Blood flow Oxygen-15 steady state technique Positron emission tomography Simulation studies
Received for publication August 5, 1991. Revision received January 9, 1992. Accepted for publication February 11, 1992.
This article has been cited by other articles:
![]() |
A. J. de Langen, V. E. M. van den Boogaart, J. T. Marcus, and M. Lubberink Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow Oncologist, June 1, 2008; 13(6): 631 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
G R Laking and P M Price Positron emission tomographic imaging of angiogenesis and vascular function Br. J. Radiol., December 1, 2003; 76(suppl_1): S50 - S59. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Herbst, N. A. Mullani, D. W. Davis, K. R. Hess, D. J. McConkey, C. Charnsangavej, M. S. O'Reilly, H.-W. Kim, C. Baker, J. Roach, et al. Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin J. Clin. Oncol., September 15, 2002; 20(18): 3804 - 3814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Hoekstra, S. G. Stroobants, O. S. Hoekstra, E. F. Smit, J. F. Vansteenkiste, and A. A. Lammertsma Measurement of Perfusion in Stage IIIA-N2 Non-Small Cell Lung Cancer Using H215O and Positron Emission Tomography Clin. Cancer Res., July 1, 2002; 8(7): 2109 - 2115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |